Skip to content
NASDAQ · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES · SMALL CAP

Lifeward Ltd. LFWD

14 fiscal years on record · USD · FY2025 reported · SEC filings only
$22.0M
▼ 14.1% YoY
$-19.9M
$-16.8M

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

We are a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. Our initial product offerings were the ReWalk Personal and ReWalk Rehabilitation Exoskeleton devices for individuals with spinal cord injury (“SCI Products”). The VHA accounted for 3.8% of our total revenue for the year ended December 31, 2025. As of December 31, 2025, we had 81 employees (including full-time and hourly employees), of whom 46 were located in the United States, 25 were located in Israel and 10 were located in Europe.

Written from the business description in Lifeward Ltd.'s annual report to the U.S. Securities and Exchange Commission, filed 18 March 2026. Every sentence was checked against that document before publication.

Growth

USD 22.0M
Revenue, FY2025 · full 14-year series below
Revenue $M Net income $M
FY2025 · Revenue 22.0 · Net income -19.9
10M20M-15M-30M
201220152018202120242025
Compound annual growth
+58.7%
+38.1%
+19.4%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +38.1% a year over the five years to FY2025.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

90 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating -89.3% · Net 90.3%
50%-200%-400%-600%
201220182025
ROE
FY2025 · ROE -146.1%
-200%-400%-600%
201220182025
Three returns, three denominators.

Each USD of equity lost 146 cents this year.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -16.8
-10M-20M
201220182025

Total assetsUSD 22.9M
EquityUSD 8.4M
CashUSD 2.2M
Current ratio1.31×

Equity funds 37% of total assets.

The 14-year record

14 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
LFWD, 14-year financial record
Metric 20252024202320222021202020192018201720162015201420132012
Revenue $B0.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Operating income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EBITDA $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
Income tax $B−0.00.0−0.00.00.00.00.0−0.00.00.00.00.00.00.0
Net income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
Free cash flow $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EPS, diluted $−17.16−39.96−31.13−2.20−0.27−0.82−2.70−14.72−30.57−2.47−2.10−6.34−74.53−41.26
Dividend / sh $◌◌◌◌◌◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend——————————————
ROE %−146.1−88.6−38.6−24.8−22.9−79.7−244.4−767.0−413.1−222.8−78.5−87.6——
Shares out B0.000.010.060.060.060.030.010.070.030.020.010.010.00◌

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures · 1 divergence in 68 reconciliationsAUDITED

Reconciled in 13 of the 14 fiscal years we could check. 1 of those reconciliations are divergences — the figures exist but don't fit the formula this check expects; that isn't the same as an error. 12 checks were skipped: the balance sheet is not tagged before 2013. Five checks were skipped: EPS is not tagged before 2012. Five checks were skipped: revenue is not tagged before 2012.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures1 divergent
ActivityOrthopedic, Prosthetic & Surgical Appliances & Supplies
Listed onNASDAQ
Incorporated inoutside the United States — SEC code L3
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2012

Share this section

Download image